Honokiol induces an autophagy and apoptosis imbalance by modulating the p62 and Nrf2 signaling loop in canine osteosarcoma
- 1Department of Animal Science & Biotechnology, College of Agriculture and Life Sciences, Chungnam National University
Abstract
Canine osteosarcoma is one of the most common cancers in dogs, primarily affecting large breeds, and is characterized by high metastatic potential and recurrence rates. However, effective treatments remain limited, necessitating the development of novel therapeutic agents. Therefore, we investigated the effects of honokiol, a bioactive compound extracted from the bark of Magnolia species, with a focus on apoptosis and autophagy, using the canine osteosarcoma cell lines DSN and D-17. Our results demonstrated that honokiol inhibited cell viability and migration while inducing apoptosis in DSN and D-17 cells. Honokiol also increased ROS generation, disrupted calcium homeostasis, and decreased mitochondrial membrane potential. In addition, honokiol downregulated Keap1 protein levels and upregulated Nrf2, phosphorylated p62, total p62, and LC3B expression in osteosarcoma cells. Furthermore, autophagic flux was confirmed by pretreatment with chloroquine, an autophagosome-lysosome fusion inhibitor. Additionally, increased numbers of acidic vesicular organelles (AVOs) were observed in honokiol-treated cells, suggesting that honokiol induces excessive autophagic flux, which may contribute to apoptosis. These findings indicate the therapeutic potential of honokiol as a novel agent against canine osteosarcoma.
Related
- Sinapaldehyde Induces Mitochondrial Dysfunction and Modulates Autophagy/Mitophagy-Associated Signaling and Apoptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells
- Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks.
- Gypenoside LI modulates autophagy-associated apoptosis in clear cell renal cell carcinoma by PPARG/PTEN/PI3K/AKT/mTOR/ULK1 signaling network
- ACSS2 phosphorylation at Ser659 attenuates neuronal apoptosis induced by cerebral ischemia-reperfusion by initiating autophagy
- Aluminum Chloride-Induced Planarian Model with Cognitive Impairments Through Neuronal Damage, Neurotransmitter Imbalance, Apoptosis, and Oxidative Stress
BibTeX
@article{seo2026honokiol,
title = {{Honokiol induces an autophagy and apoptosis imbalance by modulating the p62 and Nrf2 signaling loop in canine osteosarcoma}},
author = {Juhyeong Seo and Minha Jeong and Jiyeon Ham},
journal = {Scientific Reports},
year = {2026},
month = aug,
doi = {10.1038/s41598-026-65557-7},
url = {https://doi.org/10.1038/s41598-026-65557-7},
note = {CC BY},
}
RIS
TY - JOUR
TI - Honokiol induces an autophagy and apoptosis imbalance by modulating the p62 and Nrf2 signaling loop in canine osteosarcoma
AU - Juhyeong Seo
AU - Minha Jeong
AU - Jiyeon Ham
PY - 2026
DA - 2026/08/01
JO - Scientific Reports
DO - 10.1038/s41598-026-65557-7
UR - https://doi.org/10.1038/s41598-026-65557-7
AB - Canine osteosarcoma is one of the most common cancers in dogs, primarily affecting large breeds, and is characterized by high metastatic potential and recurrence rates. However, effective treatments remain limited, necessitating the development of novel therapeutic agents. Therefore, we investigated the effects of honokiol, a bioactive compound extracted from the bark of Magnolia species, with a focus on apoptosis and autophagy, using the canine osteosarcoma cell lines DSN and D-17. Our results demonstrated that honokiol inhibited cell viability and migration while inducing apoptosis in DSN and D-17 cells. Honokiol also increased ROS generation, disrupted calcium homeostasis, and decreased mitochondrial membrane potential. In addition, honokiol downregulated Keap1 protein levels and upregulated Nrf2, phosphorylated p62, total p62, and LC3B expression in osteosarcoma cells. Furthermore, autophagic flux was confirmed by pretreatment with chloroquine, an autophagosome-lysosome fusion inhibitor. Additionally, increased numbers of acidic vesicular organelles (AVOs) were observed in honokiol-treated cells, suggesting that honokiol induces excessive autophagic flux, which may contribute to apoptosis. These findings indicate the therapeutic potential of honokiol as a novel agent against canine osteosarcoma.
SN - 2045-2322
ER -